(UTHR) United Therapeutics - Performance 23.4% in 12m
Compare UTHR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
84.67%
#5 in Group
Rel. Strength
86.07%
#1086 in Universe
Total Return 12m
23.42%
#26 in Group
Total Return 5y
205.41%
#14 in Group
P/E 13.0
48th Percentile in Group
P/E Forward 11.3
42th Percentile in Group
PEG 1.43
87th Percentile in Group
FCF Yield 9.48%
98th Percentile in Group
12m Total Return: UTHR (23.4%) vs XBI (-18.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.95% | 23.4% | 205% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-4.81% | 21% | 36% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-7.37% | 12.7% | 62.3% | 41 | 15 | 1.05 | -18.8% | -20% |
LONN SW Lonza |
-10.4% | -7.65% | 31.6% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
BIM PA Biomerieux |
0.17% | 18.3% | 9.83% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
-15.8% | 13.7% | 1.84% | 27 | 25 | 1 | 58.7% | 15% |
ERF PA Eurofins Scientific SE |
-7.68% | -18.6% | 12.7% | 23.9 | 12.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-21.8% | -8.78% | -64.3% | 35 | 12.1 | 0.23 | -76.8% | -8.79% |
Performance Comparison: UTHR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for UTHR
Total Return (including Dividends) | UTHR | XBI | S&P 500 |
---|---|---|---|
1 Month | -4.95% | -15.39% | -11.51% |
3 Months | -17.71% | -20.11% | -14.88% |
12 Months | 23.42% | -18.40% | -1.35% |
5 Years | 205.41% | -8.01% | 105.18% |
Trend Score (consistency of price movement) | UTHR | XBI | S&P 500 |
1 Month | -26.0% | -70.7% | -8.8% |
3 Months | -77.7% | -74.4% | -65.3% |
12 Months | 56.6% | -10.2% | 80.7% |
5 Years | 91.7% | -50.1% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #35 | 12.3% | 7.42% |
3 Month | #48 | 3.01% | -3.33% |
12 Month | #25 | 51.3% | 25.1% |
5 Years | #14 | 232% | 48.9% |
FAQs
Does UTHR United Therapeutics outperforms the market?
Yes,
over the last 12 months UTHR made 23.42%, while its related Sector, the SPDR S&P Biotech (XBI) made -18.40%.
Over the last 3 months UTHR made -17.71%, while XBI made -20.11%.
Over the last 3 months UTHR made -17.71%, while XBI made -20.11%.
Performance Comparison UTHR vs Indeces and Sectors
UTHR vs. Indices UTHR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.54% | 6.56% | -5.96% | 24.8% |
US NASDAQ 100 | QQQ | 4.73% | 8.34% | -4.34% | 26.9% |
US Dow Jones Industrial 30 | DIA | 3.60% | 4.90% | -8.43% | 23.3% |
German DAX 40 | DAX | 1.77% | 6.67% | -24.3% | 11.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.01% | 2.50% | 11.7% | 18.2% |
Hongkong Hang Seng | HSI | 1.32% | 5.74% | 1.45% | 13.9% |
India NIFTY 50 | INDA | -0.68% | -5.46% | -4.76% | 28.8% |
Brasil Bovespa | EWZ | 0.09% | -4.67% | -4.12% | 42.0% |
UTHR vs. Sectors UTHR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.43% | 7.25% | -14.2% | 16.5% |
Consumer Discretionary | XLY | 2.30% | 6.09% | -10.5% | 21.3% |
Consumer Staples | XLP | -1.20% | -0.45% | -14.9% | 15.0% |
Energy | XLE | 10.6% | 2.71% | -2.00% | 40.0% |
Financial | XLF | 6.13% | 5.21% | -15.2% | 15.9% |
Health Care | XLV | 2.22% | 4.07% | -6.76% | 27.1% |
Industrial | XLI | 4.89% | 5.90% | -4.35% | 28.0% |
Materials | XLB | 4.29% | 5.70% | 0.70% | 37.9% |
Real Estate | XLRE | 1.78% | 2.20% | -8.14% | 19.3% |
Technology | XLK | 6.55% | 10.2% | 1.81% | 34.4% |
Utilities | XLU | 0.35% | -3.87% | -11.7% | 6.32% |
Aerospace & Defense | XAR | 4.67% | 4.74% | -8.07% | 17.7% |
Biotech | XBI | 4.04% | 10.4% | 7.13% | 41.8% |
Homebuilder | XHB | -0.97% | 3.24% | 6.68% | 37.2% |
Retail | XRT | 0.95% | 3.35% | -3.38% | 35.3% |